Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children Source: UC Irvine School of Medicine Irvine, CA, August 28, 2023 A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for childrens health
Step 7: Label and store
This is why injectable GLP-1 medications produce such dramatic effects on appetite and weight
They help lower blood sugar levels and promote weight loss, with Ozempic as one of the most well-known examples
Sequence: YAQGTFTSDYSILLDKKAQAAFIEYLLEGGPSSGAPPPS Molecular Formula: CHFNO Molecular Weight: 4,731.33 g/mol PubChem SID: 474492335 CAS Number: 2381089-83-2 Synonyms: LP3-R, LY-3437943, NOP2Y096GV, Triple agonist: GIP / GLP-1 / glucagon receptor agonist Source: Coskun et al., 2022 (Cell Metabolism) Wikipedia LP3-R (accessed 2025) Synthachem, 2024
Extended Data Figure 5 Structural superposition of the GLP-1R peptide 5 crystal structure with the crystal structure of the isolated GLP-1R extracellular domain in complex with the GLP-1 peptide
